Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

导出原文传递

翻译打印收藏纠错

作者： Heidecker, Bettina ^[1] ; Dagan, Noa ^[2] ; Balicer, Ran ^[3] ; Eriksson, Urs ^[4] ; Rosano, Giuseppe ^[5] ; Coats, Andrew ^[6] ; Tschoepe, Carsten ^[7] ; Kelle, Sebastian ^[8] ; Poland, Gregory A. ^[9] ; Frustaci, Andrea ^[10] ; Klingel, Karin ^[11] ; Martin, Pilar ^[12] ; Hare, Joshua M. ^[13] ; Cooper, Leslie T. ^[14] ; Pantazis, Antonis ; Imazio, Massimo ; Prasad, Sanjay ; Luscher, Thomas F.

作者单位： Free University of Berlin,Charite Univ Med Berlin ^[1] Imperial College London,Imperial Coll ^[2] Royal Brompton Hospital,Kings Coll London ^[3] St Georges Med Univ London ^[4] Monash Univ ^[5] German Heart Ctr,Charite ^[6] Mayo Clin ^[7] Dept Cardiovasc Resp Nephrol Anesthesiol & Geriat,Univ Roma La Sapienza ^[8] Inst Pathol & Neuropathol,Univ Hosp Tubingen ^[9] Citr Nacl Invest Cardiovasc ^[10] Interdisciplinary Stem Cell Inst,Univ Miami ^[11] Vaccine Res Grp,Mayo Clin ^[12] Royal Brompton Hosp ^[13] Cardiothorac Dept,Udine Univ Hlth Integrated Agcy ^[14]

关键词 COVID-19 Inflammation Myocarditis Outcomes Pathology Vaccination UNITED-STATES ENDOMYOCARDIAL BIOPSY SARS-COV-2 INFLAMMATION ADULTS

发布时间 2023-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交